Literature DB >> 7189538

Serosurvey for human babesiosis in New York.

M R Filstein, J L Benach, D J White, B A Brody, W D Goldman, C W Bakal, R S Schwartz.   

Abstract

Healthy individuals at high risk of exposure to ticks were surveyed to determine the prevalence and incidence of asymptomatic babesiosis on Shelter Island, New York, during a single transmission season. Paired sera obtained in June and October 1978 were tested for antibodies to Babesia microti by indirect immunofluorescence. Point prevalence values of 4.4% in June and 6.9% in October were obtained. Six of 102 persons tested in both months showed at least a fourfold rise in titer of antibodies to B. microti (an incidence of 5.9% for the season). None of 300 serum specimens obtained from the New York City metropolitan area had significant titers to B. microti. Of the six persons who seroconverted, four gave a history of tick bite during the transmission season; three of the four persons claimed to recognize the tick as an Ixodes dammini, the vector for B. microti.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189538     DOI: 10.1093/infdis/141.4.518

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Human Babesiosis: Pathogens, Prevalence, Diagnosis and Treatment.

Authors:  Rosalynn Louise Ord; Cheryl A Lobo
Journal:  Curr Clin Microbiol Rep       Date:  2015-09-28

2.  Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota.

Authors:  P D Mitchell; K D Reed; J M Hofkes
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  A biblical disease updated.

Authors:  D P Earle
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

Review 4.  Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti.

Authors:  David A Leiby
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 5.  Babesiosis.

Authors:  M J Homer; I Aguilar-Delfin; S R Telford; P J Krause; D H Persing
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

6.  Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman.

Authors:  C M Shih; L P Liu; W C Chung; S J Ong; C C Wang
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

7.  A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors.

Authors:  Evan M Bloch; Andrew E Levin; Phillip C Williamson; Sherri Cyrus; Beth H Shaz; Debra Kessler; Jed Gorlin; Roberta Bruhn; Tzong-Hae Lee; Leilani Montalvo; Hany Kamel; Michael P Busch
Journal:  Transfusion       Date:  2016-05-17       Impact factor: 3.157

8.  Ribosomal DNA probe for differentiation of Babesia microti and B. gibsoni isolates.

Authors:  P A Conrad; J W Thomford; A Marsh; S R Telford; J F Anderson; A Spielman; E A Sabin; I Yamane; D H Persing
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

9.  Detection of Babesia microti by polymerase chain reaction.

Authors:  D H Persing; D Mathiesen; W F Marshall; S R Telford; A Spielman; J W Thomford; P A Conrad
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Transfusion-associated babesiosis after heart transplant.

Authors:  Joseph Z Lux; Don Weiss; Jeanne V Linden; Debra Kessler; Barbara L Herwaldt; Susan J Wong; Jan Keithly; Phyllis Della-Latta; Brian E Scully
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.